Darryl Reed

Darryl Reed serves as the Chief Operating Officer at Tissue Repair Ltd, a clinical stage biopharmaceutical company focused on advanced wound healing technology since June 2021. Previously, Darryl held the position of National Sales Lead at Alexion Pharmaceuticals, overseeing a team of Regional Account Managers and driving sales strategies. As the Founder and Director of DSTM Pharma Pty Ltd from March 2019 to March 2020, Darryl established the company's vision and engaged with investors. Earlier roles include National Business Manager at Bayer Pharmaceuticals, managing healthcare professional sales teams and brand strategies, and Medical Affairs Manager at Roche. Darryl began a career in research as a Postdoctoral Fellow at the Ludwig Institute for Cancer Research. Educational qualifications include a Master's in Business Management, a Master's in Medical Science, a Ph.D. in Biochemistry and Molecular Biology, and a Bachelor of Science with Honours in Genetics and Molecular Biology.